Looking Ahead To Clinical Use Of Genome Sequencing, FDA Seeks Validation Methods
This article was originally published in The Gray Sheet
Executive Summary
A June 23 FDA meeting to begin exploring possible approaches for establishing the safety and effectiveness of whole genome sequencing technologies when used clinically fell short of producing any firm answers, with some experts saying that the technology is not yet ready for widespread clinical application.